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Abstract
Preimplanatation genetic diagnosis (PGD) allows genetic information to be tested
after an egg is fertilized in vitro before implantation into the uterus. The technology was
first used to select for embryos at risk for X-linked diseases, however it has been observed
that prospective parents are using this technology to select for the sex of their child based
on preference. This study aims to examine the views of genetic counselors towards the
use of PGD for social sex selection purposes. A survey was conducted using the online
website survey monkey’s platform and sent to members of the National Society of
Genetic Counselors through their eblast. A majority of the respondents expressed that
they were worried about the potential future of sex selection leading more offensive types
of trait selection, and they feel that the use of reproductive technology to select trait is
likely to become more commonplace over time. They showed discomfort in counseling
patients about social sex selection regardless of the patient’s age, ethnicity, or reasons
such as family balancing. Genetic counselors did not support termination of pregnancy
for sex selection purposes, but felt strongly in the right of the patient to terminate a
pregnancy regardless of the reason. Genetic counselors are concerned about their role in
the current practice regarding social sex selection. 1.They have conflicting views that on
one hand, they do not support pregnancy termination for social sex selection purposes, but
on the other hand, they believe the right of the patient in terminating a pregnancy for any
reason. The result of this study suggests that perhaps a formal discussion should take
place to explore the role of genetic counselors in this emerging area of patient service.

Background
Preimplantation genetic diagnosis (PGD) is a medical technique by which
prospective parents can inform themselves about the genetic makeup of early embryos. In
some instances, it can be used for the purposes of sex selection, either for medical
purposes or to obtain a child of the desired sex. PGD’s first use was as a tool for sex
selection, to select among embryos at risk for an X-linked disease (Delhanty, J. D., 1994).
For most X-linked diseases, male embryos are at a 50% risk of being affected, and female
embryos are at a 50% risk of being carriers. Therefore, female embryos only were
selected and implanted into the prospective mothers.

Since it first was developed in the 1980s, PGD has been used to select for single
gene disorders such as Myotonic dystrophy, Huntington’s disease, Fragile X, Bthalassemia, retinoblastoma, and spinal muscular dystrophy (Verlinsky, Y. et al, 2004).
These uses have not been free of controversy. Some argue that its use suggests a lack of
respect and tolerance for people with disabilities (Macklin, R., 2010), while others believe
that the pain and suffering experienced by children with genetic conditions and their
families should triumph over all other arguments (Botkin, J. R.,1998). Questions have
been raised about where and how to draw the line on the use of PGD, with some
suggesting that it be restricted and others deferring to the autonomy of the prospective
parents in all situations (Macklin, R., 2010).
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Ethical Issues around Terminations
PGD can be seen as unethical because it involves creating and discarding embryos.
There are different stages of life, and the timing of any form of prenatal testing could
make a significant difference in its ethical implications. It has been argued that a 3-day
old embryo is not the same as a 5 month old fetus, and hence discarding embryos and
terminating fetuses should be viewed differently (Botkin, J. R., 1998; El-Toukhy, T. et al,
2008). PGD allows parents concerned about a risk of genetic disease to know ahead of
time that the baby is unaffected, so that the anxiety associated with waiting for a prenatal
diagnosis is avoided. It also should be noted that all pregnant women have the legal right
to terminate their pregnancy for any reason before the legal cut-off time, which most of
the time in the United States is 24 weeks gestation. However, whatever one’s stand on
abortion, it is generally agreed that for ethical and medical reasons, earlier termination –
or the loss of an embryo before implantation– is a better outcome than a late termination.

Population Imbalance
The use of this technique for social sex selection has raised its own ethical issues.
Many argue that social sex selection is an act of sexism, and that the use of PGD for
social selection provides no therapeutic benefit to the child (Robertson, J. A., 2001).
Selection in favor of male fetuses is far more common worldwide, as seen in many
countries where social sex selection practiced through termination has lead to population
imbalances.
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In China, ultrasound technology became readily available to the public in the 1980s,
and abortion for the purpose of sex-selection following prenatal ultrasound became a
popular method to ensure the birth of a son. The widespread use of this practice can be
inferred by a look at sex imbalances in the population. It is estimated that there will be an
excess of 22 million men of reproductive age in China by 2025, and the consequences of
this have already been felt (Greenhalgh, S., 2013). Problems with “bride trafficking”
have came to the government’s attention, with girls in rural areas being kidnapped and
traded to other rural areas as brides to single men (Li SZ, Yan SH., 2008; Zhou, C., 2012).

In India, the first national analysis of sex-selective abortion trends, published in
2011 (Jha, P., 2011), reported sex ratio differed significantly depending on the sex of the
firstborn. Between 1991 and 2011, when the firstborn was a girl, the child sex ratio
(number of females to every 1000 males) for ages 0-6 dropped by 1.5% on average.
However, the child sex ratio for a second child did not differ from predicted norms when
the firstborn was a boy. By 2011, there were 7.1 million more boys between the ages of
0-6 than girls (Jha, P., 2011). The study also found that preference for sons had no
relation to socioeconomic status, but selective abortion did. More educated women from
richer families were more likely to use sex-selective abortion. This difference was
attributed to greater access to medical services (Jha, P., 2011).

The availability of PGD could worsen the population imbalance problems in
countries such as India and China. However, wide scale use of PGD for sex selection
might not be feasible in these countries for financial reasons, and the increased population
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imbalance that is feared might not be relevant (Macklin, R., 2010). The cost of a cycle of
IVF cycle with PGD including the medication for the induction of ovulation is
approximately $17,000 - $20,000 USD (Sherbahn, R., Accessed 2014).

Family Balancing
Family balancing is an aspect of the use of PGD for social sex selection that is
arguably more likely to be accepted by the general public. Proponents suggest that it is
not the desire for one sex over the other but a boy-girl balance that parents are seeking
(El-Toukhy, T. et al 2008; Macklin, R., 2010; Pennings, G., 1996). Family balancing is
less likely to be seen as sexist because parents with one or two children of the same sex
want a child of an opposite sex. If psychological studies support that there are biological
differences between girls and boys, then arguably those interested to experience both
should not be discouraged because of concerns about discrimination (Sermon, K. et al,
2004). On the other hand, family balancing brings up the question of stereotyping gender.
There’s a possibility that parents may put unnecessary pressure on the child to abide by
gender stereotypes, and the disappointment in failing to meet such expectations may
affect the parent-child relationship.

Slippery Slope
A public opinion survey done in 2004 with a representative sample of 4,834
Americans showed that 66% agreed with the use of PGD for fatal medical conditions, but
a majority expressed concerns about the idea of “designer babies” and distrust in the
morals of scientists developing advancements in technology. 53% agreed or strongly
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agreed that “scientists these days don't pay enough attention to the moral values of
society” (Hudson, K. L., 2006). Concerns expressed about the “slippery slope” potential
of PGD include the development of two classes of people in the future: the genetically
enhanced and the non-genetically enhanced. The average height, intelligence etc. would
be raised higher, rendering the non-genetically enhanced increasingly at a disadvantage.
The cost of PGD technology selects for a richer population, making the rich richer with
genetically enhanced “designer babies” (Brenner, D., & Brutlag, D., 2013; Hudson, K. L.,
2006).

Another concern expressed by Brenner and Brutlag is related to the welfare of the
genetically enhanced child. Talents and life choices of the child might be planned by
parents before they were born. A child with higher IQ could be, in the family’s eyes,
predetermined for a specific role, and failure to achieve such parental expectations might
result in family issues (Brenner, D., & Brutlag, D., 2013). Others are concerned about the
negative implications of “playing God”, which suggests that selecting against disability is
an act of interfering with nature (Macklin, R., 2010). The counterargument here is that
PGD is not more a disruption of nature than most of modern age medicine, where efforts
to cure disease and to prolong life expectancy are not considered inappropriate. However,
Ruth Macklin in 2010 in an article in the journal of Reproductive Medicine supporting
social sex selection for family balancing, questioned who should have the power to
regulate such advancements in medicine: the government, professional associations, or
parents?
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Laws
Some countries have laws that prevent or discourage social sex selection. Medical
sex selection in the UK is regulated by the HFEA, which has specific guidelines on the
genetic conditions for which PGD is permitted. Clinics in the UK are licensed by the
HFEA in order to perform PGD (Strange, H., & Chadwick, R., 2010). Non-medical use
of PGD for sex selection is illegal in most European countries, including the UK, as well
as Canada and Australia. However, there have been reports of couples traveling overseas
to seek such services (Macklin, R., 2010; Strange, H., & Chadwick, R., 2010).

In the United States, the American Society for Reproductive Medicine (ASRM) has
made recommendations regarding non-medical use of PDG for sex selection. Their ethics
committee released a statement in 2001 (restated in 2011) saying “the use of
preconception sex selection by pre-implantation genetic diagnosis for non-medical
reasons is ethically problematic and should be discouraged”, but “if prefertilization
techniques, particularly flow cytometry for sperm sorting, were demonstrated to be safe
and efficacious, these techniques would be ethically permissible for family balancing.
Because a pre-implantation genetic diagnosis is physically more burdensome and
necessarily involves the destruction and discarding of embryos, it was not considered
similarly permissible for family balancing”.

The Programme of Action adopted by the United Nations International Conference
on Population and Development stands against any use of sex selection techniques for any
non-medical reason, and The United Nations strongly recommend all nations "to take
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necessary measures to prevent . . . prenatal sex selection.”

In 2002, health workers in China were banned from telling parents the sex of their
child. Recently, China ordered a ban on taking blood samples of pregnant women
overseas. It had been found that medical organizations were taking blood samples to
laboratories out of the country to test for the sex of the baby (Guo, Kai, 2015). The
authorities in China appear to be taking action to address their population imbalance
issue; how stringently this will be enforced remains to be seen.

Previous Studies
Several studies have attempted to gather information on the views of healthcare
professionals regarding social sex selection. A study in 1992 investigated the views of 34
genetic counselors in the United States regarding fetal sex identification and selective
abortion, and found that an overwhelming majority of them supported the women’s right
to early termination, while objecting to prenatal diagnosis for sex selection purposes
(Burke, B. M., 1994). Another survey done in 1998 in an international population looked
at 2903 geneticists’ views on prenatal sex selection (Wilton, L., 2009). Almost half
(47%) of the respondents reported receiving open requests for social sex selection, and
half suspected social sex selection to be a reason for termination although not explicitly
revealed. Given a scenario of a family with 4 girls wanting a boy, and willing to
terminate the pregnancy if another girl was conceived, 29% reported that they would
perform prenatal diagnosis, and 38% reported that they would offer them referrals. Four
other scenarios were also studied. In each case, the number given in parentheses
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represents the percentage of geneticists who reported that they would perform prenatal
diagnosis in that situation: 1. Single woman wants a girl (35%); 2.Poor couple with five
boys want a girl (38%); 3. Non-western couple wants a boy (38%); 4. Couple in 40s
wants a girl (57%).

A 2006 study by a graduate student at the Sarah Lawrence College Human Genetics
Program examined the views of genetic counselors on sex selection for non-medical
proposes (McGuire, M., 2006). A survey was conducted through the NSGC membership
listserve and had 240 respondents. A majority (71.5%) objected to the use of ultrasound,
CVS, or amniocentesis technology for social sex selection, while 45% accepted the use of
PGD, and 68.7% accepted the use of Microsort® for social sex selection purposes.
Religion had an influence on the genetic counselors’ acceptance of PGD and sperm
sorting technologies. It was also found that the older respondents, and those who had
children, were more accepting of the use of ultrasound, CVS, or amniocentesis for social
sex selection.

This study looks at the views of genetic counselors on the issue of pre-conception
social sex selection using PGD. Genetic Counselors, especially those working in the
preconception specialty, may be the first health care provider that a patient has contact
with regarding PGD services. This study looks at how often genetic counselors are faced
with these situations at this time, and how they feel about counseling patients interested in
social sex selection.
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Methods
A survey was sent by National Society of Genetic Counselors (NSGC) eblast and
distributed to its members. The survey was created through the online website survey
monkey and approved by the Andrus Institutional Review Board on January 7, 2015.
Participants answered the survey on a voluntary basis and anonymously. The survey was
available from January 28, 2015 to February 18, 2015.

The survey contains 15 questions and took approximately 15 minutes to complete.
A 5-point Likert scale was used to collect for responses on questions regarding the views
of genetic counselors toward different prenatal tests and procedures to terminate a
pregnancy for social sex selection reasons, the potential fears they might have towards
social sex selection, and their comfort level in counseling patients seeking social sex
selection in different scenarios. Demographic information was collected regarding age,
ethnicity, years of experience practicing in the genetic counseling field, and areas of
expertise. The data was analyzed using SPSS.
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Results
The initial invitation email was sent to 3209 NSGC members with 244 responses,
yielding a response rate of 7.6%. The reminder invitation email was sent to 3236 NSGC
members with 98 responses, yielding a response rate of 3.0%. In total, 342 responses
were received, yielding a response rate of 11%. Fifty six participants provided additional
comments.
Table 1. Patient Contact for Social Sex Selection
Have you ever had patients ask you about sex selection?

Answer Options

Yes
No
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Response
Percent

n=

54.1%

125

47.6%

110

Chart 1. Frequency of Patient Contact

How	
  often	
  you	
  had	
  patients	
  ask	
  about	
  sex	
  
selection	
  	
  
12%	
  
n=15	
  
10%	
  
n=12	
  

Rarely	
  
Once	
  in	
  a	
  while	
  

18%	
  
n=22	
  

60%	
  
n=75	
  

Sometimes	
  
Frequently	
  

Chart 2. Patient Demographic Information
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Table 2. Opinion on Pregnancy Termination
For the following statements, choose “Strongly Agree”, “ Agree”, “Neutral”, “Disagree”, or “Strongly Disagree”.
Answer Options

Strongly
Agree

Agree

Neutral

Terminating a pregnancy following
1.9%
4.8%
17%
amniocentesis or CVS for purposes
(n=4)
(n=10)
(n=37)
of sex selection is acceptable.
A mother or couple has the right to
15%
49%
19%
terminate a pregnancy for sex
(n=31)
(n=103)
(n=41)
selection following an
amniocentesis or CVS.
Terminating a pregnancy following
1.4%
4.2%
14%
non-invasive prenatal testing in the
(n=3)
(n=9)
(n=30)
first trimester for the purpose of
sex selection is acceptable.
A mother or couple has the right to
14%
42%
17%
terminate a pregnancy for sex
(n=30)
(n=88)
(n=36)
selection following non-invasive
prenatal testing in the first
trimester.
Using PGD to choose embryos for
3.8%
24%
28%
purposes of sex selection is
(n=8)
(n=51)
(n=59)
acceptable.
A mother or couple has the right to
17%
46%
22%
use PGD to choose embryos for the
(n=31)
(n=98)
(n=46)
purpose of sex selection.
Sex selection to prevent X-linked
59%
36%
3.8%
disease is a good use of PGD.
(n=123)
(n=75)
(n=8)
Sex selection for family balancing
1.9%
9.0%
26%
is a good use of PGD.
(n=4)
(n=19)
(n=55)
Sex selection to provide a first
1.4%
4.3%
20%
child of a specific sex is a good use
(n=3)
(n=9)
(n=42)
of PGD.
* (1=Strongly Disagree, 2= Disagree, 3=Neutral 4=Agree, 5=Strongly Agree)

	
  

	
  

	
  
12	
  

Disagree

Strongly
Disagree

*Rating
Average

Response Count

37%
(n=79)

38%
(n=81)

1.9

211

5.7%
(n=12)

11%
(n=24)

3.5

211

34%
(n=72)

46%
(n=97)

1.8

211

12%
(n=25)

15%
(n=32)

3.3

211

24%
(n=50)

20%
(n=41)

2.7

209

9.5%
(n=20)

7.6%
(n=16)

3.5

211

1.4%
(n=3)
34%
(n=71)
37%
(n=79)

0.48%
(n=1)
29%
(n=62)
37%
(n=78)

4.5

210

2.2

211

2.0

211

Table 3. Possible Concerns Regarding Social Sex Selection
Which of the following issues affects how you view sex selection? (Check all that apply):
Answer Options
Sex selection reflects prejudice against women in the
US/Canada
Sex selection reflects prejudice against women in other
cultures
Parents should not be able to use technology to choose
traits
Sex selection might lead to other, more offensive types
of trait selection
Sex selection may create a male-female population
imbalance in other countries
Sex selection may create a male-female population
imbalance in the US/Canada
I don’t have any opposition to social sex selection

Response
Percent
26%

n=

63%

127

47%

95

70%

142

53%

108

25%

51

8.9%
Total Response

18
203

Response
Percent
3%

n=

19%

37

26%

52

36%

72

7.0%

14

1%

2

8.0%
Total Response

16
199

53

Table 4. Concerns Regarding Social Sex Selection
Which of these is the most important issue?
Answer Options
Sex selection reflects prejudice against women in the
US/Canada
Sex selection reflects prejudice against women in other
cultures
Parents should not be able to use technology to choose
traits
Sex selection might lead to other, more offensive types
of trait selection
Sex selection may create a male-female population
imbalance in other countries
Sex selection may create a male-female population
imbalance in the US/Canada
I don’t have any opposition to social sex selection
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Table 5. Views on Future Use of PGD
Do you have any fears about potential downstream negative effects of allowing sex
selection using PGD?
Answer Options
Response
Response
Percent
Count
Yes, I am very worried
14%
28
Yes, I am somewhat worried
50%
102
I am not sure
24%
49
No, I am somewhat comfortable
9%
19
No, I am comfortable
3%
7
Total Response
205
Table 6. Concern about Trait Selection
I believe the use of reproductive technology to select traits is likely to become more
commonplace over time.
Answer Options
Response
Response
Percent
Count
True
72%
148
False
28%
57
Total Response
205
Table 7. Potential Factors Affecting Patient Contact
Answer Options
A 50-year-old European
couple wanting a firstborn
son.
A 50-year-old Asian couple
wanting a firstborn son.
A 50-year-old couple
wanting a firstborn daughter.
A 25-year-old European
couple wanting a firstborn
son.
A 25-year-old Asian couple
wanting a firstborn son.
A 25-year-old couple
wanting a firstborn daughter.
A single woman wanting a
firstborn son.

No problem

Comfortable

Somewhat
comfortable

Not
comfortable

Would not
counsel

*Rating
Average

6.4%
(n=13)

13%
(n=26)

26%
(n=53)

42%
(n=84)

13%
(n=26)

3.4

6.4%
(n=13)
6.4%
(n=13)
6.4%
(n=13)

13%
(n=26)
13%
(n=27)
14%
(n=28)

27%
(n=54)
26%
(n=53)
25%
(n=51)

41%
(n=83)
41%
(n=83)
41%
(n=82)

13%
(n=26)
13%
(n=26)
14%
(n=28)

3.4

6.4%
(n=13)
6.4%
(n=13)
6.4%
(n=13)

14%
(n=28)
14%
(n=29)
14%
(n=29)

25%
(n=50)
26%
(n=52)
26%
(n=52)

41%
(n=83)
40%
(n=80)
40%
(n=81)

14%
(n=28)
14%
(n=28)
13%
(n=27)
Total Response

* (1=no problem, 2= comfortable, 3=somewhat comfortable 4=not comfortable, 5=would not counsel)
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3.4
3.4
3.4
3.4
3.4
202

Discussion
The results from our survey suggest that there is an increase in the number of
patients seeking social sex selection since 2006. In a 2006 survey of the NSGC
membership, 4% of the respondents said they saw patients seeking genetic counseling
services requesting social sex selection either “sometimes” or “frequently”. In the current
study, 22% of respondents (Chart 1) reported seeing patients seeking social sex selection
either “sometimes” (10%, n=12) or “frequently” (12%, n=15). This suggests about a fivetime increase in the number of patients seeking this service from genetic counselors.

As the literature predicts, culture and ethnicity were factors impacting who was
seeking to use PGD for sex selection and their preferred sex. When asked to describe the
scenarios they had encountered, counselors were most likely to report seeing Indian
(n=67) or Chinese (n=59) patients requesting sex selection (Chart 2). The data also
suggests that this group of patients were more likely to select for boys. They reported
seeing more than five times as many requests for selection in favor of boys than girls in
these two groups, while, for example, Northern European’s requests were not uncommon
(n=52) but sex preferences were evenly split. Several additional comments in this section
suggests that European couples were seeking social sex selection services for family
balancing reasons, which stands in contrast to the sex-biased preferences reflected
elsewhere.

Results of the study suggest that a majority of genetic counselors do not agree
with using prenatal medical tests and procedures for social sex selection (Table 2). Most
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respondents disagreed or strongly disagreed with the statement “sex selection for family
balancing is a good use of PGD” (63%, n=133) and disagreed or strongly disagreed with
the statement “Sex selection to provide a first child of a specific sex is a good use of
PGD” (74%, n=157). Counselors were somewhat sensitive to issues of timing, and far
more respondents agreed or strongly agreed that using PGD to select for embryos to
choose sex was acceptable (27.8%, n=59) than agreed or strongly agreed that termination
following amniocentesis or CVS for purposes of sex selection was acceptable (6.7%,
n=12). Overall, responses suggest that the respondents were uncomfortable with the idea
of sex selection at any point before or during pregnancy.

Despite this, a majority of genetic counselors voiced support for the right of
patients to terminate a pregnancy for sex selection reasons. Respondents supported the
right of a patient to terminate a pregnancy for social sex selection, independent of the
prenatal test or procedure used to obtain the information on the sex of the baby. Over half
of the respondents agreed with the statement “a mother or couple has the right to
terminate a pregnancy for sex selection following an amniocentesis or CVS” (64%,
n=134), and the statement “a mother or couple has the right to use PGD to choose
embryos for the purpose of sex selection” (61%, n=129). Overall, respondents were
supportive of all statements about a woman’s and couple’s right to make any of these
choices, even when they had not rated them as acceptable or a good use of the testing.
This likely indicates a strong support for abortion rights, and the right to terminate a
pregnancy for any reason. Comments like these by respondents supported this
interpretation:
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“I fully support the right to reproductive choice in our country even when it goes
against my personal values. So, while I wouldn't want to be complicit in sex selection, I
would still support their right.”
“I don't think anybody likes the idea of terminating a healthy pregnancy, but
individuals have the right to terminate a pregnancy up to certain time points for any
reason.”
“In the long run, although I don't think sex selection SHOULD be practiced, a
couple can choose to terminate a pregnancy for ANY reason, or no reason at all. It is not
up to my judgment to put limitations on that right or to be judgmental about their
culture.”

Responses to questions that specifically mentioned non-invasive prenatal screening
(NIPS) showed a small but consistent increased concern about the use of that procedure
for purposes of sex selection as compared to later procedures, which is counter-intuitive.
Participants responded negatively to a statement that it was “acceptable” to terminate for
sex selection purposes after amniocentesis or CVS (average score 1.9) but even more
negatively to an identically worded statement about NIPS (average score 1.8), and more
respondents ‘strongly disagreed’ with the statement about NIPS (46%, n=97) than
strongly disagreed with the statement about amniocentesis or CVS (38%, n=81). Again, a
slightly smaller number of respondents agreed or strongly agreed to the statement “a
mother or couple has the right to terminate a pregnancy for sex selection following non
invasive testing in the first trimester” (56%, n=118) than agreed or strongly agreed to the
statements “a mother or couple has the right to use PGD to choose embryos for the
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purpose of sex selection” (61%, n=129), or “a mother or couple has the right to terminate
a pregnancy for sex selection following amniocentesis or CVS” (63%, n=134). This
result was unexpected considering the timing of the procedures, since NIPS is the earlier
prenatal test. While the differences are small, it may suggest that the respondents were
concerned about the potential eugenic implications of the newer procedure in providing
information about the sex of the baby in the first trimester.

Respondents were unambivalent about the use of PGD for medical purposes.
Genetic counselors approved medical uses by a wide margin: 95% (n=198) of the
respondents agreed or strongly agreed with the statement “sex selection to prevent xlinked disease is a good use of PGD”.

A majority of genetic counselors (64%, n=130) expressed that they were either
“somewhat worried” or “very worried” about the downstream implications of sex
selection (Table 5). Most (72%, n=148) believed the practice would become more
common over time (Table 6). Specific concerns varied, and included sexism towards
women, creating a population imbalance, and a range of ‘slippery slope’ issues (Table 3).

Counselors showed the greatest concern about the potential that sex selection could
be a ‘slippery slope’ issue (Table 4). When asked to indicate which of a list of concerns
affected how they viewed sex selection, 70% of respondents (n=142) indicated that it
“could lead to other, more offensive forms of trait selection” (Table 3), an increase over
the 2006 study where 54% of respondents either “strongly agreed” or “agreed” with the
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statement “I am concerned that gender selection will serve as the ‘slippery slope’ for
selecting for other non medical traits such as intelligence and athletic ability”. In
addition, 47% of respondents (n=95) expressed a related concern that “parents should not
be able to use technology to choose traits”. When asked what concerned them the most,
36% (n=72) chose trait selection and 26% (n=52) pointed to parents choosing traits (Table
4). Combined, these responses suggest that respondents were extremely concerned about
the implications of being able to use PGD for non-medical purposes as use of the
technology increases.

A significant number of genetic counselors expressed concerns about sexism, but it
was not their primary concern related to sex selection. A majority of respondents (63%,
n=127) included “sex selection reflects prejudice against women in other cultures” when
asked to indicate which of a list of concerns affected how they viewed sex selection, and
26% (n=53) included “sex selection reflects prejudice against women in the US/Canada”
(Table 3). This response suggests that genetic counselors are aware of and concerned
about the issue of sex selection in cultures that favor boys, and where selection against
girls has resulted in population imbalances, however, when asked to indicate which one of
the same list of concerns they felt was the most important, only a minority of respondents
chose sexism against women in other cultures (19%, n=37), and even fewer chose sexism
against women in the US and Canada (3.0%, n=6) (Table 4).

A series of questions were designed to investigate the comfort level of genetic
counselors with different scenarios involving social sex selection, in order to investigate
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the degree to which the motivation and ethnicity of patients would be factors that would
affect the behavior or thinking of genetic counselors (Table 7). Scenarios varied as to the
age, ethnicity and marital status of the patients, as well as the number and sex of existing
siblings. Respondents described their comfort level in all scenarios as somewhere in
between “somewhat uncomfortable” and “not comfortable” in every scenario, indicating
that they are uneasy with the use of social sex selection, and that this uneasiness is not a
function of circumstances.
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Conclusion
Preimplanatation genetic diagnosis (PGD) started as a medical procedure to select
for embryos at risk of X-linked diseases, however, use to select for the sex of the embryos
for non-medical reasons is increasing. This emerging use has stirred ethical debates
regarding sexism, population imbalance, gender stereotyping, legal issues, and the fear of
a slippery slope toward the use of genetic testing for trait selection more generally.

Overall, this study suggests that genetic counselors do not support or approve of
the use of PGD for social sex selection purposes, regardless of the type of testing used or
the point at which selection occurs. Their biggest concern regarding the use of PGD for
sex selection is the concern that it will lead to an increased use of PGD for trait selection
in general. Meanwhile, conflictingly, genetic counselors show a strong belief in the right
of all patients to terminate a pregnancy even for purposes of social sex selection. The
field of genetic counseling may wish to consider how uses of PGD like sex selection can
be discouraged without creating policies that limit the rights of women and couples to
reproductive rights including termination.
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